Skip to main content
. 2014 Jun 12;8:853–864. doi: 10.2147/PPA.S53162

Figure 2.

Figure 2

LS mean IOP during a 3-month clinical trial with a 3-month safety extension.

Notes: Error bars represent SEs; *BBFC versus brinzolamide or brimonidine, P<0.001. Adapted from Nguyen QH, McMenemy MG, Realini T, Whitson JT, Goode SM. Phase 3 randomized 3-month trial with an ongoing 3-month safety extension of fixed-combination brinzolamide 1%/brimonidine 0.2%. J Ocul Pharmacol Ther. 2013;29(3):290–297.54 The publisher for this copyrighted material is Mary Ann Liebert, Inc., publishers. Copyright © 2013.

Abbreviations: BBFC, brinzolamide 1%/brimonidine 0.2% fixed combination; IOP, intraocular pressure; LS, least squares; SE, standard error.